LESAKA TECHNOLOGIES, INC.
Unaudited Condensed Consolidated Statements of Cash Flows
7
Three months ended
September 30,
2023
2022
(In thousands)
Cash flows from operating activities
Net loss
$
(5,651)
$
(10,696)
Depreciation and amortization
5,856
5,998
Movement in allowance for doubtful accounts receivable and finance loans receivable
1,525
1,049
Loss from equity-accounted investments (Note 5)
1,405
2,617
Movement in allowance for doubtful loans to equity-accounted investments
(250)
-
Fair value adjustment related to financial liabilities
(34)
63
Interest payable
1,764
26
Facility fee amortized
227
249
Net gain on disposal of equity-accounted investments (Note 5)
-
(248)
Profit on disposal of property, plant and equipment
(36)
(208)
Stock-based compensation charge (Note 12)
1,759
1,462
Dividends received from equity-accounted investments
-
21
Increase in accounts receivable and other receivables
(2,345)
(2,943)
Increase in finance loans receivable
(488)
(3,581)
Increase in inventory
(479)
(279)
Increase (Decrease) in accounts payable and other payables
375
(438)
Increase in taxes payable
308
642
Decrease in deferred taxes
(562)
(1,394)
Net cash provided by (used in) operating activities
3,374
(7,660)
Cash flows from investing activities
Capital expenditures
(2,809)
(4,501)
Proceeds from disposal of property, plant and equipment
284
417
Acquisition of intangible assets
(135)
-
Proceeds from disposal of equity-accounted investments (Note 5)
-
253
Loan to equity-accounted investment
-
112
Repayment of loans by equity-accounted investments
-
(112)
Net change in settlement assets
(11,237)
(1,884)
Net cash used in investing activities
(13,897)
(5,715)
Cash flows from financing activities
Proceeds from bank overdraft (Note 8)
59,574
146,068
Repayment of bank overdraft (Note 8)
(62,793)
(136,922)
Long-term borrowings utilized (Note 8)
2,471
1,059
Repayment of long-term borrowings (Note 8)
(2,629)
(1,580)
Acquisition of treasury stock (Note 12)
-
(185)
Proceeds from exercise of stock options
21
6
Net change in settlement obligations
10,696
1,987
Net cash provided by financing activities
7,340
10,433
Effect of exchange rate changes on cash
(443)
(8,487)
Net decrease in cash, cash equivalents and restricted cash
(3,626)
(11,429)
Cash, cash equivalents and restricted cash – beginning of period
58,632
104,800
Cash, cash equivalents and restricted cash – end of period (Note 14)
$
55,006
$
93,371
See Notes to Unaudited Condensed Consolidated Financial Statements